The Serine Protease TMPRSS6 Is Required to Sense Iron Deficiency
Open accessThe DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Abstract
Hepcidin, a liver-derived protein that restricts enteric iron absorption, is the key regulator of body iron content. Several proteins induce expression of the hepcidin-encoding gene Hamp in response to infection or high levels of iron. However, mechanism(s) of Hamp suppression during iron depletion are poorly understood. We describe mask: a recessive, chemically induced mutant mouse phenotype, characterized by progressive loss of body (but not facial) hair and microcytic anemia. The mask phenotype results from reduced absorption of dietary iron caused by high levels of hepcidin and is due to a splicing defect in the transmembrane serine protease 6 gene Tmprss6. Overexpression of normal TMPRSS6 protein suppresses activation of the Hamp promoter, and the TMPRSS6 cytoplasmic domain mediates Hamp suppression via proximal promoter element(s). TMPRSS6 is an essential component of a pathway that detects iron deficiency and blocks Hamp transcription, permitting enhanced dietary iron absorption.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Loss-of-function mutations in the negative regulator of hepcidin transcription, the transmembrane serine protease TMPRSS6 (also called matriptase 2), in mice or humans cause a disease “iron-refractory iron deficiency anemia” (IRIDA) where hepcidin is excessive despite severe iron deficiency [63,64].”
From Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis (2021) · cites this paper as [63]
In the citing paper
“where hepcidin is excessive despite severe iron deficiency [63,64]”
From Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis (2021) · cites this paper as [63]
In the citing paper
“In iron-refractory, iron-deficiency ane-mia mutations of the hepcidin inhibitor TMPRSS6 upregulate the BMP-SMAD pathway.”
From Iron metabolism and iron disorders revisited in the hepcidin era (2020) · cites this paper as [48]
In the citing paper
“The most powerful inhibitor is the liver transmembrane serine protease matriptase 2, encoded by TMPRSS6,48 which cleaves the BMP co-receptor hemojuvelin,49 thereby attenuating BMP-SMAD signaling and hepcidin transcription.”
From Iron metabolism and iron disorders revisited in the hepcidin era (2020) · cites this paper as [48]
Citations
Cites
1 retracted
Velasco, G., Cal, S., Quesada, V., Sánchez, L. M., & López-Otı́n, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203007200 · Cited by 169
RetractedHepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417
The Tumor Necrosis Factor Ligand and Receptor Families
Bazzoni, F., & Beutler, B. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342607 · Cited by 1,225
Self-citationNicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026
Self-citationMutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis
Papanikolaou, G., Samuels, M. E., Ludwig, E. H., MacDonald, M. L. E., Franchini, P. L., Dubé, M.-P., Andres, L., MacFarlane, J., Sakellaropoulos, N., Politou, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1274 · Cited by 974
Severe iron deficiency anemia in transgenic mice expressing liver hepcidin
Nicolas, G., Bennoun, M., Porteu, A., Mativet, S., Beaumont, C., Grandchamp, B., Sirito, M., Sawadogo, M., Kahn, A., & Vaulont, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072632499 · Cited by 880
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., et al. (2007) · Nature Medicine · doi:10.1038/nm1629 · Cited by 854
Regulation of Iron Metabolism by Hepcidin
Nemeth, E., & Ganz, T. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111303 · Cited by 756
Research works printed but not linked: 4
- J. Truksa, P. Lee, H. Peng, J. Flanagan, E. Beutler, Blood110, 3436 (2007).
- S. S. Watowich, D. J. Hilton, H. F. Lodish, Mol. Cell. Biol.14, 3535 (1994).
- C. Delocheet al., Eur. J. Dermatol.17, 507 (2007).
- E. S. Russell, E. C. McFarland, E. L. Kent, Transplant. Proc.2, 144 (1970).
Cited by
Items 101–200 of 627
Macrophages and Iron Metabolism
Ganz, T. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0037-2016 · Cited by 129
Hepcidin in human iron disorders: Therapeutic implications
Pietrangelo, A. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.004 · Cited by 116
Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis
Core, A. B., Canali, S., & Babitt, J. L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00104 · Cited by 106
Iron Homeostasis During Pregnancy: Maternal, Placental, and Fetal Regulatory Mechanisms
Sangkhae, V., Fisher, A. L., Ganz, T., & Nemeth, E. (2023) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-061021-030404 · Cited by 125
Hepcidin antagonists for potential treatments of disorders with hepcidin excess
Poli, M., Asperti, M., Ruzzenenti, P., Regoni, M., & Arosio, P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00086 · Cited by 124
The Liver in Regulation of Iron Homeostasis
Rishi, G., & Subramaniam, V. N. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00004.2017 · Cited by 124
“Hfe / High High Low (103) Tfr2 / High High Low (13, 22, 92) Hjv / High High Low (34, 61) Bmp6 / High High Low (55, 84) AlbCre / Smad4 f/f High High Low (95) Tmprss6 / Low Low High (14, 21, 24) Hfe / /Tfr2 / High High Low (90) Hfe / Hjv / High High Low (41) Hjv / /Tfr2 / High High Low (32) Hjv / /Tmprss6 / High High Lo…”
BackgroundIron metabolism: current facts and future decisions
Tandara, L., & Salamunic, I. (2012) · Biochemia Medica · doi:10.11613/bm.2012.034 · Cited by 93
Hepcidin: clinical utility as a diagnostic tool and therapeutic target
Coyne, D. W. (2011) · Kidney International · doi:10.1038/ki.2011.141 · Cited by 116
Iron-Refractory Iron Deficiency Anemia (IRIDA)
Heeney, M. M., & Finberg, K. E. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2014.04.009 · Cited by 117
Clinical Relevance of Anemia and Transfusion Iron Overload in Myelodysplastic Syndromes
Cazzola, M., Porta, M. G. D., & Malcovati, L. (2008) · Hematology · doi:10.1182/asheducation-2008.1.166 · Cited by 114
Nai, A., Pagani, A., Silvestri, L., Campostrini, N., Corbella, M., Girelli, D., Traglia, M., Toniolo, D., & Camaschella, C. (2011) · Blood · doi:10.1182/blood-2011-06-364034 · Cited by 113
Kleinman, S. H., Busch, M. P., Murphy, E. L., Shan, H., Ness, P. M., & Glynn, S. A. (2013) · Transfusion · doi:10.1111/trf.12468 · Cited by 113
Crawford, J. M., & Liu, C. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0792-2.50023-7 · Cited by 113
How Much Nutritional Iron Deficiency in Humans Globally Is due to an Underlying Zinc Deficiency?
Graham, R. D., Knez, M., & Welch, R. M. (2012) · Advances in agronomy · doi:10.1016/b978-0-12-394276-0.00001-9 · Cited by 112
Type II transmembrane serine proteases in cancer and viral infections
Choi, S.-Y., Bertram, S., Glowacka, I., Park, Y. W., & Pöhlmann, S. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.05.003 · Cited by 112
Interacting signals in the control of hepcidin expression
Darshan, D., & Anderson, G. J. (2009) · BioMetals · doi:10.1007/s10534-008-9187-y · Cited by 113
Weiss, G., Theurl, I., Eder, S., Koppelstaetter, C., Kurz, K., Sonnweber, T., Kobold, U., & Mayer, G. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02182.x · Cited by 107
Gardenghi, S., Grady, R. W., & Rivella, S. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.003 · Cited by 95
An, P., Wu, Q., Wang, H., Guan, Y., Mu, M., Liao, Y., Zhou, D., Song, P., Wang, C., Meng, L., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds028 · Cited by 100
Gender-related variations in iron metabolism and liver diseases
Harrison-Findik, D. D. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i8.302 · Cited by 109
Expression of the iron hormone hepcidin distinguishes different types of anemia in African children
Pasricha, S.-R., Atkinson, S. H., Armitage, A. E., Khandwala, S., Veenemans, J., Cox, S. E., Eddowes, L. A., Hayes, T., Doherty, C. P., Demir, A. Y., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008249 · Cited by 108
“Genetic lesions that cause increased hepcidin result in an iron deficiency anemia that is resistant to oral iron supplementation (13, 14).”
BackgroundGarrick, M. D., & Garrick, L. M. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.03.018 · Cited by 111
Wilson, K. C., & Sloan, J. M. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1507104 · Cited by 106
The importance of eukaryotic ferritins in iron handling and cytoprotection
Arosio, P., Carmona, F., Gozzelino, R., Maccarinelli, F., & Poli, M. (2015) · Biochemical Journal · doi:10.1042/bj20150787 · Cited by 104
Iron in Health and Disease: An Update
Lal, A. (2019) · The Indian Journal of Pediatrics · doi:10.1007/s12098-019-03054-8 · Cited by 105
Xu, Y., Alfaro-Magallanes, V. M., & Babitt, J. L. (2020) · British Journal of Haematology · doi:10.1111/bjh.17252 · Cited by 103
Ineffective Erythropoiesis: Anemia and Iron Overload
Gupta, R., Musallam, K. M., Taher, A. T., & Rivella, S. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.11.009 · Cited by 90
Iron metabolism and the role of the iron-regulating hormone hepcidin in health and disease
Daher, R., Manceau, H., & Karim, Z. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2017.10.006 · Cited by 100
Ehsani, S. (2020) · Biology Direct · doi:10.1186/s13062-020-00275-2 · Cited by 100
Recycling Iron in Normal and Pathological States
Beaumont, C., & Delaby, C. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2009.06.004 · Cited by 104
Traglia, M., Girelli, D., Biino, G., Campostrini, N., Corbella, M., Sala, C., Masciullo, C., Viganò, F., Buetti, I., Pistis, G., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100061 · Cited by 97
“mice homozygous for a truncated matriptase-2 lacking the serine protease domain,”
BackgroundNai, A., Rubio, A., Campanella, A., Gourbeyre, O., Artuso, I., Bordini, J., Gineste, A., Latour, C., Besson-Fournier, C., Lin, H. Y., et al. (2016) · Blood · doi:10.1182/blood-2015-11-681494 · Cited by 97
“Patients andmatriptase-2–deficient mice display microcytic hypochromic anemia, low serum iron, and reduced transferrin saturation due to high hepcidin level.(16,17) In vitro studies have shown that matriptase-2 cleaves HJV,(18) attenuating the BMP-SMAD pathway activation and reducing hepcidin expression.”
BackgroundDonker, A. E., Raymakers, R. A. P., Vlasveld, L. T., van Barneveld, T., Terink, R., Dors, N., Brons, P. P. T., Knoers, N. V. A. M., & Swinkels, D. W. (2014) · Blood · doi:10.1182/blood-2014-01-548776 · Cited by 83
Iron-Sensing Proteins that Regulate Hepcidin and Enteric Iron Absorption
Knutson, M. D. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104801 · Cited by 96
Iron Overload in Sickle Cell Disease
Raghupathy, R., Manwani, D. G., & Little, J. A. (2010) · Advances in Hematology · doi:10.1155/2010/272940 · Cited by 95
β-Thalassemia intermedia: a comprehensive overview and novel approaches
Asadov, C. D., Alimirzoyeva, Z., Mammadova, T., Aliyeva, G., Gafarova, S., & Mammadov, J. (2018) · International Journal of Hematology · doi:10.1007/s12185-018-2411-9 · Cited by 94
Bone morphogenic proteins in iron homeostasis
Xiao, X., Alfaro-Magallanes, V. M., & Babitt, J. L. (2020) · Bone · doi:10.1016/j.bone.2020.115495 · Cited by 94
Poli, M., Luscieti, S., Gandini, V., Maccarinelli, F., Finazzi, D., Silvestri, L., Roetto, A., & Arosio, P. (2010) · Haematologica · doi:10.3324/haematol.2010.027003 · Cited by 80
Zhang, A.-S., Yang, F., Wang, J., Tsukamoto, H., & Enns, C. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.027318 · Cited by 82
An overview of the genetic aspects of hair loss and its connection with nutrition
Gökçe, N., Basgoz, N., Kenanoğlu, S., Akalın, H., Özkul, Y., Ergören, M. Ç., Beccari, T., Bertelli, M., & Dündar, M. (2022) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2022.63.2s3.2765 · Cited by 92
The role of adipocytes in the modulation of iron metabolism in obesity
Coimbra, S., Catarino, C., & Santos‐Silva, A. (2013) · Obesity Reviews · doi:10.1111/obr.12057 · Cited by 79
Xavier-Ferrucio, J. M., Scanlon, V. M., Li, X., Zhang, P., Lozovatsky, L., Ayala‐Lopez, N., Tebaldi, T., Halene, S., Cao, C. Q., Fleming, M. D., et al. (2019) · Blood · doi:10.1182/blood.2019002039 · Cited by 88
Mocchegiani, E., Costarelli, L., Giacconi, R., Piacenza, F., Basso, A., & Malavolta, M. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.01.004 · Cited by 88
Theurl, I., Schroll, A., Nairz, M., Seifert, M., Theurl, M., Sonnweber, T., Kulaksiz, H., & Weiss, G. (2011) · Haematologica · doi:10.3324/haematol.2011.048926 · Cited by 76
Therapeutic potential of hepcidin − the master regulator of iron metabolism
Vyoral, D., & Petrák, J. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.010 · Cited by 85
The role of TMPRSS6/matriptase-2 in iron regulation and anemia
Wang, C., Meynard, D., & Lin, H. Y.-F. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00114 · Cited by 85
Iron Homeostasis and Its Interaction with Prolyl Hydroxylases
Mole, D. R. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2790 · Cited by 82
Hepcidin: Homeostasis and Diseases Related to Iron Metabolism
Reichert, C. O., da Cunha, J., Levy, D., Maselli, L. M. F., Bydlowski, S. P., & Spada, C. (2017) · Acta Haematologica · doi:10.1159/000471838 · Cited by 85
Fine tuning of hepcidin expression by positive and negative regulators
Muckenthaler, M. U. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.009 · Cited by 83
“Consistent with the findings in mask mutant (Du et al., 2008) and TMPRSS6 knockout (Folgueras et al., 2008) mice, urinary hepcidin tabolism 8, July 2008 ª2008 Elsevier Inc. 1 levels in individuals with IRIDA are inappropriately high, although hepcidin is typically undetectable in patients with iron…”
BackgroundResultInfluentialFang, J., Liu, C.-H., Hsu, R., Chen, Y.-Y., Chiang, W., Wang, H., & Hu, S. (2020) · Polymers · doi:10.3390/polym12061392 · Cited by 83
Hershko, C., & Skikne, B. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2009.06.002 · Cited by 83
Genetic mechanisms and modifying factors in hereditary hemochromatosis
Weiss, G. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.201 · Cited by 82
Diagnosis of iron-deficient states
Archer, N. M., & Brugnara, C. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1038744 · Cited by 82
Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice
Finberg, K. E., Whittlesey, R. L., & Andrews, N. C. (2011) · Blood · doi:10.1182/blood-2010-10-315507 · Cited by 81
Maternal hepcidin determines embryo iron homeostasis in mice
Sangkhae, V., Fisher, A. L., Chua, K. J., Ruchala, P. P., Ganz, T., & Nemeth, E. (2020) · Blood · doi:10.1182/blood.2020005745 · Cited by 81
Lambrecht, R. W., Sterling, R. K., Naishadham, D., Stoddard, A. M., Rogers, T. E., Morishima, C., Morgan, T. R. M., & Bonkovsky, H. L. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.053 · Cited by 81
Pichler, I., Minelli, C., Sanna, S., Tanaka, T., Schwienbacher, C., Naitza, S., Porcu, E., Pattaro, C., Busonero, F., Zanon, A., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq552 · Cited by 76
Oral iron therapy: Current concepts and future prospects for improving efficacy and outcomes
Ebea, P. O., Vidyasagar, S., Connor, J. R., Frazer, D. M., Knutson, M. D., & Collins, J. F. (2024) · British Journal of Haematology · doi:10.1111/bjh.19268 · Cited by 79
Genes for iron metabolism influence circadian rhythms in Drosophila melanogaster
Mandilaras, K., & Missirlis, F. (2012) · Metallomics · doi:10.1039/c2mt20065a · Cited by 78
Ethnic Differences in Iron Status
Kang, W., Barad, A., Clark, A. G., Wang, Y., Xu, L., Gu, Z., & O'Brien, K. O. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab035 · Cited by 79
Neogenin Interacts with Matriptase-2 to Facilitate Hemojuvelin Cleavage
Enns, C. A., Ahmed, R., & Zhang, A.-S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.363937 · Cited by 63
Gan, W., Guan, Y., Wu, Q., An, P., Zhu, J., Lu, L., Li, J., Yu, Y., Ruan, S., Xie, D., et al. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.025684 · Cited by 76
Szabo, R., Sales, K. U., Kosa, P. F., Shylo, N. A., Godiksen, S., Hansen, K. K., Friis, S., Gutkind, J. S., Vogel, L. K., Hümmler, E., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002937 · Cited by 75
Mleczko-Sanecka, K., Roche, F., Rita da Silva, A., Call, D., D’Alessio, F., Ragab, A., Lapinski, P. E., Ummanni, R., Korf, U., Oakes, C., et al. (2014) · Blood · doi:10.1182/blood-2013-07-515957 · Cited by 74
Identification of the First Low-Molecular-Weight Inhibitors of Matriptase-2
Sisay, M. T., Steinmetzer, T., Stirnberg, M., Maurer, E., Hammami, M., Bajorath, J., & Gütschow, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100183e · Cited by 68
Metformin potentiates nephrotoxicity by promoting NETosis in response to renal ferroptosis
Cai, Z., Wu, X., Song, Z., Sun, S., Su, Y., Wang, T., Cheng, X., Yu, Y., Yu, C., Chen, E., et al. (2023) · Cell Discovery · doi:10.1038/s41421-023-00595-3 · Cited by 73
Truksa, J., Gelbart, T., Peng, H., Beutler, E., Beutler, B., & Lee, P. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07873.x · Cited by 65
Self-citationWahedi, M., Wortham, A. M., Kleven, M. D., Zhao, N., Jue, S. F., Enns, C. A., & Zhang, A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.801795 · Cited by 72
Polymorphisms and mutations of human TMPRSS6 in iron deficiency anemia
Beutler, E., Geet, C. V., Loo, D. M. W. M. T., Gelbart, T., Crain, K., Truksa, J., & Lee, P. L. (2009) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2009.09.001 · Cited by 71
Self-citationDevelopment of a novel immunoassay for the iron regulatory peptide hepcidin
Busbridge, M., Griffiths, C., Ashby, D., Gale, D., Jayantha, A., Sanwaiya, A., & Chapman, R. S. (2009) · British Journal of Biomedical Science · doi:10.1080/09674845.2009.11730263 · Cited by 64
Barré, O., Dufour, A., Eckhard, U., Kappelhoff, R., Béliveau, F., Leduc, R., & Overall, C. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105984 · Cited by 70
Molecular basis of iron-loading disorders
Darshan, D., Frazer, D. M., & Anderson, G. J. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001687 · Cited by 64
Ramsay, A. J., Quesada, V., Sanchez, M., Garabaya, C., Sardà, M. P., Baiget, M., Remacha, A., Velasco, G., & López-Otín, C. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp315 · Cited by 64
Macrophage ferroportin is essential for stromal cell proliferation in wound healing
Recalcati, S., Gammella, E., Buratti, P., Doni, A., Anselmo, A., Locati, M., & Cairo, G. (2018) · Haematologica · doi:10.3324/haematol.2018.197517 · Cited by 70
Miniaci, M. C., Irace, C., Capuozzo, A., Piccolo, M., Pascale, A. D., Russo, A., Lippiello, P., Lepre, F., Russo, G., & Santamaria, R. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25286 · Cited by 70
de Tayrac, M., Roth, M.-P., Jouanolle, A.-M., Coppin, H., le Gac, G., Piperno, A., Férec, C., Pelucchi, S., Scotet, V., Bardou-Jacquet, E., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.017 · Cited by 62
The molecular basis of iron overload disorders and iron-linked anemias
Kaplan, J., Ward, D. M., & Domenico, I. D. (2011) · International Journal of Hematology · doi:10.1007/s12185-010-0760-0 · Cited by 69
Maxson, J. E., Chen, J., Enns, C. A., & Zhang, A.-S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.183160 · Cited by 60
Novel TMPRSS6 mutations associated with iron-refractory iron deficiency anemia (IRIDA)
De Falco, L., Totaro, F., Nai, A., Pagani, A., Girelli, D., Silvestri, L., Piscopo, C., Campostrini, N., Dufour, C., Manjomi, F. A., et al. (2010) · Human Mutation · doi:10.1002/humu.21243 · Cited by 63
Anemia of Chronic Disease (Anemia of Inflammation)
Agarwal, N., & Prchal, J. T. (2009) · Acta Haematologica · doi:10.1159/000243794 · Cited by 68
Disorders associated with systemic or local iron overload: from pathophysiology to clinical practice
Sebastiani, G., & Pantopoulos, K. (2011) · Metallomics · doi:10.1039/c1mt00082a · Cited by 57
Stirnberg, M., Maurer, E., Horstmeyer, A., Kolp, S., Frank, S., Bald, T., Arenz, K., Janzer, A., Prager, K., Wunderlich, P., et al. (2010) · Biochemical Journal · doi:10.1042/bj20091565 · Cited by 66
Varga, E., Pap, R., Jánosa, G., Sipos, K., & Pandur, E. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03322-0 · Cited by 65
Hepcidin: A Critical Regulator of Iron Metabolism during Hypoxia
Hintze, K. J., & McClung, J. P. (2011) · Advances in Hematology · doi:10.1155/2011/510304 · Cited by 58
Laboratory and Genetic Assessment of Iron Deficiency in Blood Donors
Kiss, J. E. (2014) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2014.10.011 · Cited by 63
De Falco, L., Silvestri, L., Kannengiesser, C., Morán, E., Oudin, C., Rausa, M., Bruno, M., Aranda, J., Argiles, B., Yenicesu, I., et al. (2014) · Human Mutation · doi:10.1002/humu.22632 · Cited by 54
Low Intracellular Iron Increases the Stability of Matriptase-2
Zhao, N., Nizzi, C. P., Anderson, S. A., Wang, J., Ueno, A., Tsukamoto, H., Eisenstein, R. S., Enns, C. A., & Zhang, A.-S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.611913 · Cited by 51
Darshan, D., Frazer, D. M., Wilkins, S. J., & Anderson, G. J. (2010) · Haematologica · doi:10.3324/haematol.2010.022426 · Cited by 61
The extrahepatic role of TFR2 in iron homeostasis
Silvestri, L., Nai, A., Pagani, A., & Camaschella, C. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00093 · Cited by 51
Control of Systemic Iron Homeostasis by the Hemojuvelin-Hepcidin Axis
Zhang, A. (2010) · Advances in Nutrition · doi:10.3945/an.110.1009 · Cited by 61
Ferristatin II Promotes Degradation of Transferrin Receptor-1 In Vitro and In Vivo
Byrne, S. L., Buckett, P. D., Kim, J., Luo, F., Sanford, J. C., Chen, J., Enns, C. A., & Wessling‐Resnick, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070199 · Cited by 60
Inherited disorders of iron metabolism
Camaschella, C., & Poggiali, E. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283425591 · Cited by 59
Crosstalk between Iron Metabolism and Erythropoiesis
Li, H., & Ginzburg, Y. Z. (2010) · Advances in Hematology · doi:10.1155/2010/605435 · Cited by 59
Factors influencing disease phenotype and penetrance in HFE haemochromatosis
Rochette, J., Gac, G. L., Lassoued, K., Férec, C., & Robson, K. (2010) · Human Genetics · doi:10.1007/s00439-010-0852-1 · Cited by 58
Iron deficiency and diffuse nonscarring scalp alopecia in women: More pieces to the puzzle
Pierre, S. A. S., Vercellotti, G. M., Donovan, J., & Hordinsky, M. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.05.054 · Cited by 58
Iron-refractory iron deficiency anemia: new molecular mechanisms
Cui, Y., Wu, Q., & Zhou, Y. (2009) · Kidney International · doi:10.1038/ki.2009.357 · Cited by 60
Is the iron regulatory hormone hepcidin a risk factor for alcoholic liver disease?
Harrison-Findik, D.-D. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1186 · Cited by 56
TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis
Ganz, T., Nemeth, E., Rivella, S., Goldberg, P., Dibble, A., McCaleb, M. L., Guo, S., Monia, B. P., & Barrett, T. D. (2023) · Advances in Therapy · doi:10.1007/s12325-022-02421-w · Cited by 56
Matriptase-2 deficiency protects from obesity by modulating iron homeostasis
Folgueras, A. R., Freitas-Rodríguez, S., Ramsay, A. J., Garabaya, C., Rodríguez, F., Velasco, G., & López-Otín, C. (2018) · Nature Communications · doi:10.1038/s41467-018-03853-1 · Cited by 49
Iron Deficiency, Helicobacter Infection and Gastritis
Hershko, C., & Ronson, A. (2009) · Acta Haematologica · doi:10.1159/000243793 · Cited by 55
Metadata
- Authors
- Du, X., She, E., Gelbart, T., Truksa, J., Lee, P., Xia, Y., Khovananth, K., Mudd, S., Mann, N., Moresco, E. M. Y., Beutler, E., & Beutler, B.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Beutler, Bruce
- Venue
- Science
- Published
- 2008-05-23
- Volume
- 320
- Issue
- 5879
- Pages
- 1088-1092
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC2430097
- OpenAlex
- W2108843246
- Cited by
- 578
- References
- 27
- Citations by year
- 2026: 14 · 2025: 12 · 2024: 17 · 2023: 15 · 2022: 19 · 2021: 27 · 2020: 22 · 2019: 28 · 2018: 29 · 2017: 25 · 2016: 32 · 2015: 25 · 2014: 43 · 2013: 46 · 2012: 48
- FWCI
- 37.87
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (U54AI054523, AI054523)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK53505-09, R01DK053505)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Plant Micronutrient Interactions and Effects
- Keywords
- TMPRSS6, hepcidin, iron deficiency, dietary iron absorption, microcytic anemia, aberrant splicing, transcriptional repression, iron homeostasis, transmembrane serine protease
- MeSH terms
- Iron Deficiencies, Anemia, Macrocytic, Animals, Gene Expression Regulation, Humans, Iron, Membrane Proteins, Mice, Mutant Strains, Mice, Transgenic, Models, Biological, Mutation, Phenotype, Promoter Regions, Genetic, Serine Endopeptidases, Transfection, Signal Transduction, Protein Structure, Tertiary, Antimicrobial Cationic Peptides, Cell Line, Tumor, Mice, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.